PRESS RELEASE published on 10/14/2024 at 19:16, 1 year 1 month ago Inside Information / Other news releases Ikonisys completes €478k capital increase through private placement, enhancing financial resources and expanding shareholder base. Details of the transaction and impact on shareholders revealed Private Placement Capital Increase Financial Resources Ikonisys Shareholder Impact
BRIEF published on 10/10/2024 at 07:35, 1 year 1 month ago Hospitex International wins tender in Italy Italy Call For Tenders Ikonisys Hospitex International Cancer Diagnosis
PRESS RELEASE published on 10/10/2024 at 07:30, 1 year 1 month ago Inside Information / Other news releases Ikonisys announces that Hospitex International has won a public tender to supply diagnostic systems to U.O.C. Pathological Anatomy Unit in Enna, Italy, reinforcing dedication to innovative cancer diagnosis solutions Ikonisys Hospitex International Cancer Diagnosis Public Tender Diagnostic Systems
BRIEF published on 09/09/2024 at 08:05, 1 year 2 months ago Ikonisys launches the Ikoniscope Max in Europe Digital Pathology Early Detection Ikoniscope Max Pathology Congress Cytology And FISH
PRESS RELEASE published on 09/09/2024 at 08:00, 1 year 2 months ago Inside Information / Other news releases Ikonisys launches Ikoniscope Max in Europe at 36th European Congress of Pathology in Florence, offering groundbreaking digital pathology solution for precise and fast cancer detection Europe Cancer Detection Ikonisys Pathology Ikoniscope Max
BRIEF published on 08/15/2024 at 07:05, 1 year 3 months ago Ikonisys completes a capital increase of €150,000 Private Placement Funding Capital Increase New Actions Ikonisys
PRESS RELEASE published on 08/15/2024 at 07:00, 1 year 3 months ago Inside Information / Other news releases Ikonisys completes €150k capital increase via private placement to strengthen financial resources and support working capital needs, enhancing shareholder base and financial visibility Private Placement Capital Increase Financial Resources Shareholder Base Ikonisys
BRIEF published on 07/23/2024 at 10:11, 1 year 4 months ago Ikonisys SA Receives Buy Rating Despite Lower 2023 Figures Private Placement Financial Results 2023 Performance Sphene Capital Ikonisys
PRESS RELEASE published on 07/23/2024 at 10:06, 1 year 4 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Sphene Capital GmbH updates research report on Ikonisys SA, adjusting price target to EUR 5.50 from EUR 6.30. Company's 2023 financial figures below expectations, 2024 forecasts driven by collaborations Financial Figures Ikonisys SA Price Target Collaborations Sphene Capital GmbH
BRIEF published on 07/18/2024 at 19:10, 1 year 4 months ago Ikonisys Completes €250k Capital Increase Via Private Placement Private Placement Capital Increase Financial Resources Cancer Detection Ikonisys
Published on 12/05/2025 at 02:35, 9 hours 19 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours 54 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 49 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 54 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:30, 1 hour 24 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 39 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 13 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 2 hours 24 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 08:45, 3 hours 9 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 54 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 9 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 10 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
